American International Group, Inc. Sesen Bio, Inc. Transaction History

American International Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.38 - $0.89 $37,979 - $88,952	-99,947 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.58 - $0.86 $4,080 - $6,050	-7,035 Reduced 6.58%	99,947 $60,000
Q4 2021 Feb 11, 2022	SELL	$0.73 - $1.28 $940 - $1,649	-1,289 Reduced 1.19%	106,982 $87,000
Q3 2021 Nov 12, 2021	BUY	$0.77 - $4.91 $9,608 - $61,271	12,479 Added 13.03%	108,271 $86,000
Q2 2021 Aug 13, 2021	BUY	$2.18 - $4.66 $208,826 - $446,390	95,792 New	95,792 $443,000

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.